Metlife (MET) stock
Last close $97.60 on 2026-11-19 (-2.19%) · Sector: Financial Services
MetLife is one of the largest life insurance companies in the world, offering life, dental, disability, and retirement products to individuals and employers. It earns money mainly from premiums customers pay for their policies, and from investing the large pool of money it holds until claims and benefits are paid.
MetLife's revenue grew 14.7% over the latest year, and its latest quarter reported net income of $2.4 billion, the highest in the period shown. Over the past year the stock returned 32.0%, well ahead of the S&P 500's 9.7%, though it is 8.5% below its 52-week high of $106.72. The CEO sold $19.3 million of stock in November, the largest insider sale in the data, and the stock has usually fallen the day after earnings reports, rising after only one of the last four.
Key numbers
- Market cap: $62.5B
- Revenue (last 12 months): $82.55B
- Revenue growth: +14.7%
- Operating margin: 8.2%
- P/E: 12.7
- P/S: 0.8
- Debt to equity: 0.85
Quality score
Overall 54/100 · growth 42 · profitability 30 · financial health None · value 89
Performance and risk
1-year return +32.0% vs S&P 500 +9.7% · volatility 23.7% (S&P 500 13.8%) · largest drop -18.1% · beta 0.65
Stock move the day after earnings
- 2026-02-04: -3.4%
- 2026-05-06: -1.7%
- 2026-08-05: +3.8%
- 2026-11-04: -3.1%
Insider trades (12 months)
Bought $0.0M · sold $21.0M
MET stock research · MET options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.